Survivors of Childhood and Adolescent Cancer

- Overview

- Algorithms of Late Effects by Disease

- Facilitating Assessment of Late Effects by Organ System

- Pediatric Growth and Development: Impact on Vulnerability to Normal Tissue Damage from Cancer Therapy

- Central Nervous System Effects

- Neuroendocrine Complications of Cancer Therapy

- Ocular Complications due to Cancer Treatment

- Head and Neck

- Adverse Effects of Cancer Treatment on Hearing

- The Thyroid Gland

- Cardiovascular Effects of Cancer Therapy

- Pulmonary Effects of Antineoplastic Therapy

- Late Gastrointestinal and Hepatic Effects

- The Ovary

- The Testes

- Genitourinary

- Musculoskeletal, Integument

- Breast

- Hematopoietic Stem Cell Transplantation

- Second Malignancies Following Treatment for Childhood Cancer

- Psychological Aspects of Long-Term Survivorship

- Legal Issues

- Methodological Issues in the Study of Survivors of Childhood Cancer

- Survivorship Transitions following Childhood and Adolescent Cancer

- Health Maintenance and Promotion

Cindy L. Schwartz, MD, MPH is Division Head and Chair of Pediatrics ad interim at MD Anderson Cancer Center, Houston, TX. She is the Edgar Lewis Curtis, Savilla Elizabeth Curtis and Eleanor Lewis Curtis Distinguished Professor in Pediatric Cancer. Previously she was the Director of Pediatric Hematology-Oncology at Hasbro Children's Hospital, Brown University, Providence, Rhode Island, Associate Director of Clinical Programs in Pediatric Oncology at Johns Hopkins and Interim Director of Pediatric Hematology Oncology at the University of Rochester. She has developed and led programs for pediatric cancer survivors at these institutions. Professor Schwartz was the Chair of the Childrens and Pediatric Oncology Groups' Hodgkin Lymphoma Committees from 1999-2011 and has led many national clinical trials in Hodgkin Lymphoma and osteosarcoma. She has been named in America's Top Doctors for each of the past 14 years. She has served on the editorial boards of the Journal of ClinicalOncology and Pediatric Blood and Cancer and is a reviewer for many other journals. She has been a member of National Cancer Institute advisory committees and has been Chair of the DSMB of the NANT (Novel Approaches to Neuroblastoma Therapy). She is author or co-author of more than 70 original publications in peer-reviewed journals as well as many book chapters.

Louis S. Constine, MD, FASTRO is Professor of Radiation Oncology and Pediatrics and Vice Chair of the Department of Radiation Oncology, and was awarded fellowship in his professional society, The American Society of Radiation Oncology. After graduating from Stanford University, and The Johns Hopkins University School of Medicine, he trained in pediatrics, pediatric oncology and radiation oncology, and has board certification in these areas. His clinical and scientific expertise is in lymphomas, sarcomas, all pediatric malignancies, and the broad area of Survivorship that includes the acute and chronic effects of chemotherapy and

"This volume reviews systematically in 24 chapters the sequelae of cancer therapy on all body systems and organs. ... Written by multidisciplinary teams it has many colored photos and tables and references. A textbook highly recommended to pediatric oncologists, endocrinologists, roentgenologists and health teams who care for children after cancer therapy." (Zvi Laron, Pediatric Endocrinology Reviews, Vol. 13 (4), June, 2016)


"This book is designed to bring attention to the long-term complications induced by cancer treatments of children. ... The audience includes healthcare professionals in the many disciplines who care for oncology patients -- physicians, nurses, and physical therapy, speech therapy, occupational therapy,and mental health providers. ... There are many high quality pictures and graphs throughout the book." (Melissa Mason, Doody's Book Reviews, February, 2016)